Pulmonary embolism in a morbidly obese patient receiving dabigatran

Clin Cardiol. 2017 Sep;40(9):777. doi: 10.1002/clc.22755. Epub 2017 Jul 10.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antithrombins / administration & dosage*
  • Blood Coagulation / drug effects*
  • Body Mass Index
  • Dabigatran / administration & dosage*
  • Drug Substitution
  • Humans
  • Male
  • Middle Aged
  • Obesity, Morbid / blood
  • Obesity, Morbid / complications*
  • Obesity, Morbid / diagnosis
  • Pulmonary Embolism / blood
  • Pulmonary Embolism / diagnosis
  • Pulmonary Embolism / etiology
  • Pulmonary Embolism / prevention & control*
  • Risk Factors
  • Rivaroxaban / administration & dosage
  • Treatment Failure

Substances

  • Antithrombins
  • Rivaroxaban
  • Dabigatran